Correlation between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by FibroScan in Rheumatoid Arthritis Patients

Correlation between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by FibroScan in Rheumatoid Arthritis Patients

<i>Background and Objectives</i>: Methotrexate (MTX) is routinely prescribed for rheumatoid arthritis (RA) patients, but high cumulative doses may lead to hepatic fibrosis. Additionally, a high proportion of RA patients suffer from metabolic syndrome, which also increases the risk of hep...

Full description

Bibliographic Details
Main Authors: Ratchaya Lertnawapan, Soonthorn Chonprasertsuk, Sith Siramolpiwat, Kanon Jatuworapruk
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Medicina
Subjects:
rheumatoid arthritis
methotrexate
DMARDs
hepatic fibrosis
metabolic syndrome
Online Access:https://www.mdpi.com/1648-9144/59/6/1029

Similar Items

Similar Items